B-Cell Lymphoma, Unspecified

Clinical trial pipeline · Data from ClinicalTrials.gov

See which B-Cell Lymphoma, Unspecified trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT00935090

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-\[18F\] fluorothymidine (FLT) PET imaging, may help find and diagnose cancer. It may also help doctors pre…

United StatesStarted 2009-09

Treatment: 3'-deoxy-3'-[18F]fluorothymidine

RecruitingNot Applicable

NCT01137825

Registry of Older Patients With Cancer

RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering informa…

United States3,000 participantsStarted 2009-09

All recent trials (100 shown)

Active — Not RecruitingPhase 1

NCT02992522

Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

This phase I study studies the side effects and best dose of venetoclax and lenalidomide when given together with obinutuzumab in treating patients with B-cell…

United States22 participantsStarted 2017-02-21

Treatment: Lenalidomide, Obinutuzumab

WithdrawnPhase 1/2

NCT05613348

CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/Lymphoma

This study aims to evaluate the safety and efficacy of humanized Anti-CD19 Chimeric Antigen Receptor-T cell (CAR19T2 T cell) in children with refractory/relapse…

China0Started 2022-12-01

Treatment: CD19 CAR T-Cell(CAT19T2)

B-Cell Lymphoma, Unspecified

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Registry of Older Patients With Cancer

All recent trials (100 shown)

Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/Lymphoma

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Registry of Older Patients With Cancer

All recent trials (100 shown)

Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/Lymphoma

A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma

Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Soli…

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapse…

Collecting and Storing Blood Samples From Patients With Cancer

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Pa…

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer

Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

Treatment for Chronic Pain in Patients With Advanced Cancer

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma